FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to the use of an agent intended for improving male reproductive function, and can be used to increase sperm cell viability and activity. Use of the inhalation composition consists of the following gases, wt.%: argon – 65-75%, oxygen – 25-35%, as an agent for increasing sperm cell viability.
EFFECT: declared invention enables to achieve high activity and viability of sperm cells by using a gas mixture containing the declared amount of oxygen and argon.
1 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INCREASING VIABILITY AND ACTIVITY OF SPERM CELLS | 2024 |
|
RU2835742C1 |
| MEANS AND METHOD FOR IMPROVING SPERM QUALITY | 1999 |
|
RU2159122C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING REPRODUCTIVE AND ERECTILE DYSFUNCTIONS IN MEN AND USE THEREOF | 2023 |
|
RU2825382C1 |
| COMPOSITION FOR IMPROVEMENT OF THE MALE REPRODUCTIVE FUNCTION | 2017 |
|
RU2665636C2 |
| USE OF OXIDISED DEXTRAN FOR TREATING AND PREVENTING INFECTIOUS-INFLAMMATORY DISORDERS OF SPERMATOGENESIS | 2023 |
|
RU2814617C1 |
| COMPOSITION FOR IMPORVEMENT OF HUMAN REPRODUCTION | 2016 |
|
RU2616521C1 |
| METHOD OF IMPROVING AND/OR RECOVERY OF REPRODUCTIVE FUNCTION | 2009 |
|
RU2414215C1 |
| USE OF COMPLEX OF 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH β-CYCLODEXTRIN FOR TREATMENT OF PATHOZOOSPERMIA | 2019 |
|
RU2782140C2 |
| METHOD OF EXPERIMENTAL STIMULATION OF SPERMATOGENESIS | 2011 |
|
RU2481132C1 |
| RECTAL MEDICINAL AGENT FOR CORRECTION OF SPERMATOGENESIS DISORDERS IN MALE INFERTILITY | 2017 |
|
RU2686334C2 |
